Gotham Asset Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Gotham Asset Management's ABMD Position: Q4 2022 in Review
Gotham Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,632 shares — an estimated $892K sold.
Gotham Asset Management first reported a position in ABMD in Q1 2014 and held it in 15 quarters. The position peaked at $6.89M in Q4 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Gotham Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Gotham Asset Management sold 3,632 Abiomed Inc shares in Q4 2022, an estimated $892K.
- Gotham Asset Management first reported a position in Abiomed Inc in Q1 2014 and held it in 15 quarters.
- Gotham Asset Management's Abiomed Inc position peaked at $6.89M in Q4 2019.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Gotham Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.